Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

CMV-Seropositive Recipients Are at Higher Risk of CMV Reactivation and NRM after Haploidentical-SCT with PT-Cy

Jacopo Mariotti, Stefania Bramanti, Raynier Devillier, MD PhD, Barbara Sarina, Sabine Furst, MD, Angela Granata, MD, Valerio Maisano, MD, Thomas Pagliardini, MD, Chiara De Philippis, MD, Catherine Faucher, MD, Samia Harbi, MD, Christian Chabannon, MD PhD, Carmelo Carlo-Stella, MD, Reda Bouabdallah, Armando Santoro, Didier Blaise, MD PhD, Luca Castagna

Blood (2019) 134 (Supplement_1): 4484.

https://doi.org/10.1182/blood-2019-125101

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Improves Outcome of Patients > 60 Years with Acute Myeloid Leukemia in First Complete Remission: A 10-Year Single Center Transplantation Program Analysis

Raynier Devillier, Jerome Rey, MD, Samia Harbi, MD, Aude Charbonnier, MD, Sabine Furst, MD, Colombe Saillard, MD, Angela Granata, MD, Evelyne D'Incan, MD, Catherine Faucher, MD, Claude Lemarie, Pharm.D., Faezeh Legrand, MD, Boris Calmels, Pharm.D., Valerio Maisano, MD, Bilal Mohty, MD, Christian Chabannon, MD PhD, Pierre Jean Weiller, MDPhD, Didier Blaise, Norbert Vey

Blood (2017) 130 (Supplement 1): 3327.

https://doi.org/10.1182/blood.V130.Suppl_1.3327.3327

Published: 2017

Journal Articles

Use of G-CSF after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

Valerio Maisano, MD, Raynier Devillier, Sabine Furst, MD, Faezeh Legrand, MD, Samia Harbi, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Angela Granata, MD, Pierre Jean Weiller, MDPhD, Didier Blaise

Blood (2017) 130 (Supplement 1): 5536.

https://doi.org/10.1182/blood.V130.Suppl_1.5536.5536

Published: 2017

Journal Articles

Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)

Angela Granata, MD, Raynier Devillier, Stefania Bramanti, MD, Sabine Furst, MD, Faezeh Legrand, MD, Samia Harbi, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Claude Lemarie, Pharm.D., Boris Calmels, Pharm.D., Jacopo Mariotti, Valerio Maisano, MD, Pierre Jean Weiller, MDPhD, Luca Castagna, MD, Didier Blaise

Blood (2017) 130 (Supplement 1): 1984.

https://doi.org/10.1182/blood.V130.Suppl_1.1984.1984

Published: 2017

Journal Articles

The Minnesota Refined Acute GVHD Score Predicts Response to Initial Therapy, Survival and Non-Relapse Mortality after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Jacopo Mariotti, Angela Granata, MD, Raynier Devillier, Stefania Bramanti, MD, Barbara Sarina, MD, Sabine Furst, MD, Catherine Faucher, MD, Samia Harbi, MD, Lucio Morabito, Christian Chabannon, MD PhD, Carmelo Carlo-Stella, MD, Reda Bouabdallah, MD, Armando Santoro, MD, Didier Blaise, Luca Castagna, MD

Blood (2017) 130 (Supplement 1): 4485.

https://doi.org/10.1182/blood.V130.Suppl_1.4485.4485

Published: 2017

Journal Articles

Haploidentical Hematopoietic Stem Cell Allogeneic Transplantation with High Dose Post Transplantation Cyclophosphamide for Patients over 60 Years of Age

Samia Harbi, MD, Raynier Devillier, Stefania Bramanti, MD, Thomas Pagliardini, Faezeh Legrand, MD, Maud Cecile, Valerio Maisano, MD, Cecile Braticevic, Angela Granata, MD, Frederique Rousseau, Sabine Furst, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, pierre Jean Weiller, Luca Castagna, MD, Didier Blaise

Blood (2017) 130 (Supplement 1): 2035.

https://doi.org/10.1182/blood.V130.Suppl_1.2035.2035

Published: 2017

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients over 60 Years with Acute Myeloid Leukemia: A Single Center Donor Comparison

Raynier Devillier, Sabine Furst, MD, Jerome Rey, MD, Angela Granata, MD, Aude Charbonnier, MD, Samia Harbi, MD, Evelyne D'Incan, MD, Thomas Pagliardini, Catherine Faucher, MD, Claude Lemarie, Pharm.D., Colombe Saillard, MD, Faezeh Legrand, MD, Boris Calmels, Pharm.D., Bilal Mohty, MD, Valerio Maisano, MD, Christian Chabannon, MD PhD, Pierre Jean Weiller, MDPhD, Norbert Vey, Didier Blaise

Blood (2017) 130 (Supplement 1): 2038.

https://doi.org/10.1182/blood.V130.Suppl_1.2038.2038

Published: 2017

Journal Articles

Donor Lymphocyte Infusion after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Clemence Roux, Samia Harbi, MD, Raynier Devillier, MDPhD, Faezeh Legrand, Sabine Fürst, MD, Angela Granata, MD, Stefania Bramanti, MD, Catherine Faucher, MD, Jean ElCheikh, Djamel Mokart, Christian Chabannon, MD PhD, Boris Calmels, Pierre-Jean Weiller, Prof., Luca Castagna, MD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 5863.

https://doi.org/10.1182/blood.V128.22.5863.5863

Published: 2016

Journal Articles

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Sabine Fürst, MD, Jean El Cheikh, MD PhD, Bénédicte Devictor, MD, Sandra Cournier, Angela Granata, MD, Samia Harbi, MD, Raynier Devillier, MD PhD, Faezeh Legrand, MD, Stefania Bramanti, MD, Claude Lemarie, PharmD, Jean Pierre Weiller, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Borje S. Andersson, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 5751.

https://doi.org/10.1182/blood.V128.22.5751.5751

Published: 2016

Journal Articles

Early Post Transplant Organ Toxicity after Allogeneic One-Haplotype Mismatch (Haplo) Hematopoietic Stem Cell Transplant (HSCT)

Didier Blaise, MD PhD, Clemence Mediavilla, Amir Meskine, Stéfania Bramanti, Samia Harbi, MD, Sabine Furst, MD, Catherine Faucher, MD, Angela Granata, MD, Faezeh Legrand, Djamel Mokart, Pierre Jean Weiller, MD, Christian Chabannon, MD PhD, Jérome Rey, Diane Coso, Luca Castagna, Raynier Devillier, MD PhD

Blood (2016) 128 (22): 5754.

https://doi.org/10.1182/blood.V128.22.5754.5754

Published: 2016

Journal Articles

Chimerism Analysis after Haploidentical Stem Cell Transplantation: Is It Necessary for All Patients?

Faezeh Legrand, MD, Valerio Maisano, MD, Sabine Fürst, MD, Angela Granata, MD, Marie Joelle Mozziaconacci, MD, Catherine Faucher, MD, Claude Lemarie, PharmD, Samia Harbi, MD, Christophe Picard, MD PhD, Stephania Bramanti, MD, Boris Calmels, PharmD, PhD, Christian Chabannon, MD PhD, Raynier Devillier, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 3417.

https://doi.org/10.1182/blood.V128.22.3417.3417

Published: 2016

Journal Articles

Impact of Cytopenia Following Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophoshamide

Villetard Ferdinand, Stefania Bramanti, MD, Samia Harbi, MD, Sabine Fürst, MD, Catherine Faucher, MD, Angela Granata, MD, Faezeh Legrand, Djamel Mokart, Pierre-Jean Weiller, Prof., Christian Chabannon, MD PhD, Aude Charbonnier, Anne-Marie Stoppa, MD, Luca Castagna, MD, Didier Blaise, MD PhD, Raynier Devillier, MDPhD

Blood (2016) 128 (22): 2281.

https://doi.org/10.1182/blood.V128.22.2281.2281

Published: 2016

Journal Articles

Haploidentical Stem Cell Transplantation for Patients Relapsing after First Allogeneic Transplantation

Virginie Lavoipierre, Samia Harbi, MD, Luca Castagna, MD, Angela Granata, MD, Sabine Fürst, MD, Catherine Faucher, MD, Faezeh Legrand, Stefania Bramanti, MD, Christian Chabannon, MD PhD, Norbert Vey, MD PhD, Jérome Rey, Reda Bouabdallah, MD, Jean Marc Schiano De Colella, Djamel Mokart, Pierre-Jean Weiller, Prof., Didier Blaise, MD PhD, Raynier Devillier, MD PhD

Blood (2016) 128 (22): 4618.

https://doi.org/10.1182/blood.V128.22.4618.4618

Published: 2016

Journal Articles

Low Incidence of Chronic Gvhd after Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation with Post Transplantation Cyclophosphamide (PT-Cy)

Angela Granata, MD, Sabine Furst, MD, Jean marie Boher, Luca Castagna, MD, Patrice Chevallier, MD PhD, Alice Garnier, MD, Thierry Guillaume, MD PhD, Remy Dulery, MD, Mohamad Mohty, Faezeh Legrand, Samia Harbi, MD, Raynier Devillier, MD PhD, Catherine Faucher, MD, Stefania Bramanti, MD, Claude Lemarie, PharmD, Boris Calmels, PharmD, PhD, Pierre Jean Weiller, MD, Christian Chabannon, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 4594.

https://doi.org/10.1182/blood.V128.22.4594.4594

Published: 2016

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation From Haploidentical Donor After Reduced Intensity Conditioning Regimen Allows Promising Disease Control In Patients With Hematological Diseases

Raynier Devillier, MD, Luca Castagna, Roberto Crocchiolo, MD PhD, Sabine Furst, MD, Samia Harbi, Jean El Cheikh, MD, Angela Granata, Bilal Mohty, MD, Catherine Faucher, MD, Didier Blaise, MD

Blood (2013) 122 (21): 2139.

https://doi.org/10.1182/blood.V122.21.2139.2139

Published: 2013

Journal Articles

Role Of Allogeneic Transplant In Poor Risk CLL Patients: A Long-Term Monocentric Experience In 39 Patients

Therese Aurran-Schleinitz, MD, Anne Wanquet, Sabine Furst, MD, Benjamin Esterni, Ph.D., Reda Bouabdallah, MD, Diane Coso, MD, Christine Arnoulet, Pharm. D., Jean El Cheikh, MD, Catherine Faucher, MD, Luca Castagna, MD, Christian Chabannon, MD, PhD, Didier Blaise

Blood (2013) 122 (21): 5531.

https://doi.org/10.1182/blood.V122.21.5531.5531

Published: 2013

Journal Articles

Reduced Intensity Conditioning Based On Fludarabine, Intravenous Busulfan (2 Days) and Antithymocyte Globulins (2 Days) Results In High Disease Free Survival Without Persisting Gvhd In Patients Transplanted For Hematological Malignancies: Large Single Center Cohort With Long Follow-Up

Raynier Devillier, MD, Sabine Furst, MD, Roberto Crocchiolo, MD PhD, Samia Harbi, Luca Castagna, Jean El Cheikh, MD, Angela Granata, Catherine Faucher, MD, Anne Marie Stoppa, Bilal Mohty, MD, Thomas Prebet, MD, PhD, Diane Coso, MD, Jerome Rey, MD, Reda Bouabdallah, MD, Norbert Vey, MD, Didier Blaise, MD

Blood (2013) 122 (21): 3364.

https://doi.org/10.1182/blood.V122.21.3364.3364

Published: 2013

Journal Articles

LOW Tranplant Related Mortality and LOW GRAFT Rejection After Related Haploidentical STEM CELL Transplantation (HAPLO-SCT) Prepared with NON Myeloablative CONDITIONING REGIMEN (NMA) and Posttransplant Cyclophosphamide for Advanced Lymphoid Malignancies.

Sabine Furst, MD, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Catherine Faucher, MD, Claire Oudin, Angela Granata, Geoffroy Venton, Claude Lemarie, Diane Coso, MD, Reda Bouabdallah, MD, Anne Marie Stoppa, Norbert Vey, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 3031.

https://doi.org/10.1182/blood.V120.21.3031.3031

Published: 2012

Journal Articles

High Response RATE and NO Treatment Related Mortality After Brentuximab Vedotin Salvage Therapy Followed by Reduced Intensity Conditioning Regimen Allogeneic STEM CELL Transplantation (RIC-ALLO) in Patients with CD 30+ Lymphomas

Sabine Furst, MD, Reda Bouabdallah, MD, Diane Coso, MD, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Catherine Faucher, MD, Angela Granata, Claire Oudin, Geoffroy Venton, Anne Marie Stoppa, Claude Lemarie, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 4526.

https://doi.org/10.1182/blood.V120.21.4526.4526

Published: 2012

Journal Articles

Allogeneic Stem Cell Transplantation From Matched Related Donor in Patients Over the Age of 55 Years: A Prospective Multicenter Phase II Study of a Reduced Intensity Conditioning Associating Fludarabin-IV Busulfan and Thymoglobulin

Didier Blaise, MD, Mohamad Mohty, Noel Milpied, MD, Anne Gaelle Lecorroller, PhD, Nathalie Fegueux, Sabine Furst, MD, Patrice Chevallier, MD, Reza Tabrizi, MD, Mauricette Michallet, MD, PhD, Jean Yves Cahn, MD, Anne Sirvent, MD, Jacques-Olivier Bay, MD, PhD, Jean El Cheikh, MD, PhD, Catherine Faucher, MD, Roberto Crocchiolo, MD, Agnes Boyer-Chamard, MD, Luca Castagna, MD, Jean Marie Boher, PhD

Blood (2011) 118 (21): 1952.

https://doi.org/10.1182/blood.V118.21.1952.1952

Published: 2011

NARROW

CMV-Seropositive Recipients Are at Higher Risk of CMV Reactivation and NRM after Haploidentical-SCT with PT-Cy

Allogeneic Hematopoietic Stem Cell Transplantation Improves Outcome of Patients > 60 Years with Acute Myeloid Leukemia in First Complete Remission: A 10-Year Single Center Transplantation Program Analysis

Use of G-CSF after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide

Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)

The Minnesota Refined Acute GVHD Score Predicts Response to Initial Therapy, Survival and Non-Relapse Mortality after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Haploidentical Hematopoietic Stem Cell Allogeneic Transplantation with High Dose Post Transplantation Cyclophosphamide for Patients over 60 Years of Age

Allogeneic Hematopoietic Stem Cell Transplantation for Patients over 60 Years with Acute Myeloid Leukemia: A Single Center Donor Comparison

Donor Lymphocyte Infusion after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Early Post Transplant Organ Toxicity after Allogeneic One-Haplotype Mismatch (Haplo) Hematopoietic Stem Cell Transplant (HSCT)

Chimerism Analysis after Haploidentical Stem Cell Transplantation: Is It Necessary for All Patients?

Impact of Cytopenia Following Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophoshamide

Haploidentical Stem Cell Transplantation for Patients Relapsing after First Allogeneic Transplantation

Low Incidence of Chronic Gvhd after Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation with Post Transplantation Cyclophosphamide (PT-Cy)

Allogeneic Hematopoietic Stem Cell Transplantation From Haploidentical Donor After Reduced Intensity Conditioning Regimen Allows Promising Disease Control In Patients With Hematological Diseases

Role Of Allogeneic Transplant In Poor Risk CLL Patients: A Long-Term Monocentric Experience In 39 Patients

Reduced Intensity Conditioning Based On Fludarabine, Intravenous Busulfan (2 Days) and Antithymocyte Globulins (2 Days) Results In High Disease Free Survival Without Persisting Gvhd In Patients Transplanted For Hematological Malignancies: Large Single Center Cohort With Long Follow-Up

LOW Tranplant Related Mortality and LOW GRAFT Rejection After Related Haploidentical STEM CELL Transplantation (HAPLO-SCT) Prepared with NON Myeloablative CONDITIONING REGIMEN (NMA) and Posttransplant Cyclophosphamide for Advanced Lymphoid Malignancies.

High Response RATE and NO Treatment Related Mortality After Brentuximab Vedotin Salvage Therapy Followed by Reduced Intensity Conditioning Regimen Allogeneic STEM CELL Transplantation (RIC-ALLO) in Patients with CD 30+ Lymphomas

Allogeneic Stem Cell Transplantation From Matched Related Donor in Patients Over the Age of 55 Years: A Prospective Multicenter Phase II Study of a Reduced Intensity Conditioning Associating Fludarabin-IV Busulfan and Thymoglobulin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only